2-HETEROARYL-IMIDAZOTRIAZINONES AND THEIR USE IN THE TREATMENT OF INFLAMMATORY OR IMMUNE DISEASES

The invention relates to 2-Heteroaryl-imidazotriazinones, processes for thei r preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases. The present invention relates to compounds of the general formula (I) in which R1 denot...

Full description

Saved in:
Bibliographic Details
Main Authors NIEWOEHNER, ULRICH, SCHAUSS, DAGMAR, HENDRIX, MARTIN, GEISS, VOLKER, FITZGERALD, MARY F, BISCHOFF, HILMAR, STURTON, GRAHAM, BURKHARDT, NILS, SCHLEMMER, KARL-HEINZ, CUTHBERT, NIGEL, ALONSO-ALIJA, CRISTINA, GIELEN, HEIKE
Format Patent
LanguageEnglish
French
Published 12.12.2002
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to 2-Heteroaryl-imidazotriazinones, processes for thei r preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases. The present invention relates to compounds of the general formula (I) in which R1 denote s 5- to 10- membered heteroaryl, which is optionally substituted by identical or different residues selected from the group consisting of halogen, (C1-C4)- alkyl, trifluoromthyl, cyano, nitro und trifluoromethoxy, denotes 3-to 10- membered carbocyclyl or carbon-bonded, 4- to 10-membered heterocyclyl, where by carbocyclyl and heterocyclyl are optionally substituted by identical or different residues selected from the group consisting of (C1-C6)-aldyl, (C1- C6)-aldoxy, hydroxy, halogen, trifluoromethyl and oxo, or denotes (C2-C10)- alkyl, which is optionally substituted by identical or different residues selected from the group the group consisting of (C1-C6)-alkoxy, hydroxy, halogen, 3-to 10-membered carbocyclyl and oxo.
AbstractList The invention relates to 2-Heteroaryl-imidazotriazinones, processes for thei r preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases. The present invention relates to compounds of the general formula (I) in which R1 denote s 5- to 10- membered heteroaryl, which is optionally substituted by identical or different residues selected from the group consisting of halogen, (C1-C4)- alkyl, trifluoromthyl, cyano, nitro und trifluoromethoxy, denotes 3-to 10- membered carbocyclyl or carbon-bonded, 4- to 10-membered heterocyclyl, where by carbocyclyl and heterocyclyl are optionally substituted by identical or different residues selected from the group consisting of (C1-C6)-aldyl, (C1- C6)-aldoxy, hydroxy, halogen, trifluoromethyl and oxo, or denotes (C2-C10)- alkyl, which is optionally substituted by identical or different residues selected from the group the group consisting of (C1-C6)-alkoxy, hydroxy, halogen, 3-to 10-membered carbocyclyl and oxo.
Author HENDRIX, MARTIN
BISCHOFF, HILMAR
NIEWOEHNER, ULRICH
GIELEN, HEIKE
STURTON, GRAHAM
GEISS, VOLKER
FITZGERALD, MARY F
BURKHARDT, NILS
SCHAUSS, DAGMAR
CUTHBERT, NIGEL
ALONSO-ALIJA, CRISTINA
SCHLEMMER, KARL-HEINZ
Author_xml – fullname: NIEWOEHNER, ULRICH
– fullname: SCHAUSS, DAGMAR
– fullname: HENDRIX, MARTIN
– fullname: GEISS, VOLKER
– fullname: FITZGERALD, MARY F
– fullname: BISCHOFF, HILMAR
– fullname: STURTON, GRAHAM
– fullname: BURKHARDT, NILS
– fullname: SCHLEMMER, KARL-HEINZ
– fullname: CUTHBERT, NIGEL
– fullname: ALONSO-ALIJA, CRISTINA
– fullname: GIELEN, HEIKE
BookMark eNqNijsKg0AQQLdIivzuMBcQorGxHHTEAXcXZsdCG5GwqYIK5v4kgRwg1eM93tHs5mWOBzNlSUNK4lH6NmHLFQ5ehXFg5x0FQFeBNsQCXSBg9xVQIVRLTsHXn1a3aC2qlx68AFvbOYKKA2GgcDb7x_Tc4uXHk4GatGySuC5j3NbpHuf4GkvM8rxIrwWmtz-WN7MANSE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 2-HETEROARYL-IMIDAZOTRIAZINONES ET UTILISATION DANS LE TRAITEMENT DE MALADIES INFLAMMATOIRES OU IMMUNITAIRES
Edition 7
ExternalDocumentID CA2449109A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2449109A13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:02:32 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2449109A13
Notes Application Number: CA20022449109
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021212&DB=EPODOC&CC=CA&NR=2449109A1
ParticipantIDs epo_espacenet_CA2449109A1
PublicationCentury 2000
PublicationDate 20021212
PublicationDateYYYYMMDD 2002-12-12
PublicationDate_xml – month: 12
  year: 2002
  text: 20021212
  day: 12
PublicationDecade 2000
PublicationYear 2002
RelatedCompanies BAYER HEALTHCARE AG
RelatedCompanies_xml – name: BAYER HEALTHCARE AG
Score 2.5679169
Snippet The invention relates to 2-Heteroaryl-imidazotriazinones, processes for thei r preparation and their use in medicaments, esp. for the treatment and/or...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 2-HETEROARYL-IMIDAZOTRIAZINONES AND THEIR USE IN THE TREATMENT OF INFLAMMATORY OR IMMUNE DISEASES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021212&DB=EPODOC&locale=&CC=CA&NR=2449109A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8IwsCFo1DdFjfiVPpi9LbIxC3tYTFm7bIatZAwDvJCtjISXQWTGv-91YeiLvrXX5NJec1-93h1CT5bdMyRRMXWy6uiWtIDnpJ3paZYqa3plEaLyncOI-BPrbfoybaB1nQtT1Qn9qoojAkdJ4Peyktfbn0csVv2t3D1nawBtXr3EYVrtHYMgNkyNDRw-Eky4mus6LtWi2AEtBorRpuAoHSkrWpXZ5-8DlZSy_a1RvHN0PAJkRXmBGnnRQqdu3XithU7CfbwbhnvW212i1NR9DranoPFsqIPIYXQukjig8yASER9jGjGc-DyI8WTMcRCpCU5iThNVrx8LD2DekIYhTUQ8wyLGQRhOIo5ZMOYUxOoVwh5PXF-HvS4OdFm49HCq7jVqFpsiv0HYyGWakW5PLq3c6shV3-zZcAWmJEvSN5d5G7X_RHP7z9odOqs7oRjmPWqWH5_5AyjkMnusSPkNTEqHlw
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT4MwsFmmUd90apyffTC8EQfDMh4W00EJKLQLY2bbywIdS_bCFofx73uQMX3Rt_aaXNpr7qvXu0Po0bBMTZIypk6WHdWQBvCctFI1SZPSml4ahJT5ziEn3th4nTxPGmhV58JUdUK_quKIwFES-L2o5PXm5xHLqf5Wbp_SFYDWL27cd5TaOwZBrOmKM-izoXCErdh236YKj_qgxUAxWhQcpQMTPMLKU3oflEkpm98axT1Fh0NAlhdnqJHlLXRs143XWugo3MW7Ybhjve05SnTVY2B7ChpNAxVEjkNnIo58OvO54GyEKXdw7DE_wuMRwz4vJziOGI3Lev1YuABzAxqGNBbRFIsI-2E45gw7_ohREKsXCLsstj0V9jrf02Vu0_2pupeoma_z7AphLZNJSrqmXBiZ0ZHLnm5acAW6JAvS0xdZG7X_RHP9z9oDOvbiMJgHPn-7QSd1VxRNv0XN4uMzuwPlXKT3FVm_AcjcioE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2-HETEROARYL-IMIDAZOTRIAZINONES+AND+THEIR+USE+IN+THE+TREATMENT+OF+INFLAMMATORY+OR+IMMUNE+DISEASES&rft.inventor=NIEWOEHNER%2C+ULRICH&rft.inventor=SCHAUSS%2C+DAGMAR&rft.inventor=HENDRIX%2C+MARTIN&rft.inventor=GEISS%2C+VOLKER&rft.inventor=FITZGERALD%2C+MARY+F&rft.inventor=BISCHOFF%2C+HILMAR&rft.inventor=STURTON%2C+GRAHAM&rft.inventor=BURKHARDT%2C+NILS&rft.inventor=SCHLEMMER%2C+KARL-HEINZ&rft.inventor=CUTHBERT%2C+NIGEL&rft.inventor=ALONSO-ALIJA%2C+CRISTINA&rft.inventor=GIELEN%2C+HEIKE&rft.date=2002-12-12&rft.externalDBID=A1&rft.externalDocID=CA2449109A1